We are live on
!
Find out more
RP
Repertoire Partners Portfolio holdings
AUM
$143M
1-Year Est. Return
28.83%
This Fund
S&P 500
This Quarter
Est. Return
-8.86%
1 Year Est. Return
-28.83%
3 Year Est. Return
-37.48%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$300M
AUM Growth
-$1.24B
(-80%)
Cap. Flow
-$1.06B
Cap. Flow
% of AUM
-352.07%
Top 10 Holdings %
Top 10 Hldgs %
83.73%
Holding
93
New
40
Increased
10
Reduced
12
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ryder
R
|
+$7.94M |
| 2 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$4.01M |
| 3 |
XM
Qualtrics International Inc. Class A Common Stock
XM
|
+$2.65M |
| 4 |
RDUS
Radius Health, Inc.
RDUS
|
+$2.6M |
| 5 |
SGI
Somnigroup International
SGI
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BGC Group
BGC
|
+$20.8M |
| 2 |
Turning Point Brands
TPB
|
+$20M |
| 3 |
Perimeter Solutions
PRM
|
+$15.7M |
| 4 |
DNB
Dun & Bradstreet
DNB
|
+$12.1M |
| 5 |
DOOR
MASONITE INTERNATIONAL CORP
DOOR
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.09% |
| 2 | Industrials | 6.71% |
| 3 | Consumer Discretionary | 6.24% |
| 4 | Materials | 4.19% |
| 5 | Consumer Staples | 1.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HMHC
76
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $2K | ﹤0.01% |
100
| – | – |
|
77
ADT
ADT
$5.51B
| $1K | ﹤0.01% |
100
| – | – |
|
78
Alamos Gold
AGI
$11.9B
| $1K | ﹤0.01% |
100
-99,900
| -100% | -$777K |
|
|
ETWO
79
DELISTED
E2open Parent Holdings
ETWO
| $1K | ﹤0.01% |
100
| – | – |
|
80
Hayward Holdings
HAYW
$3.26B
| $1K | ﹤0.01% |
100
-44,761
| -100% | -$690K |
|
81
Liberty Latin America Class C
LILAK
$1.61B
| $1K | ﹤0.01% |
110
| – | – |
|
82
Pennant Group
PNTG
$1.43B
| $1K | ﹤0.01% |
100
| – | – |
|
83
Purple Innovation
PRPL
$31.6M
| $1K | ﹤0.01% |
13
| – | – |
|
84
Standard BioTools
LAB
$351M
| $0 | ﹤0.01% |
100
| – | – |
|
85
nVent Electric
NVT
$23.4B
| – | – |
-100
| Closed | -$3K |
|
86
Unilever
UL
$141B
| – | – |
-89
| Closed | – |
|
87
Willis Towers Watson
WTW
$31.7B
| – | – |
-100
| Closed | -$24K |
|
|
MIME
88
DELISTED
Mimecast Limited
MIME
| – | – |
-1,000
| Closed | -$80K |
|
|
NLSN
89
DELISTED
Nielsen Holdings plc
NLSN
| – | – |
-1,000
| Closed | -$27K |
|
Similar funds
CMS
PWM
AL
DWM
EFA
DRP
CWM
SCM
Repertoire Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Repertoire Partners held 93 positions worth $300M, down 80% from $1.54B the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Repertoire Partners withdrew a net $1.06B in Q2 2022, closing 5 positions and reducing 12 holdings. Its most notable exit was Mimecast Limited, an estimated $80K position sold in full.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 5.2% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Repertoire Partners opened a new position in Tabula Rasa HealthCare, Inc. Common Stock worth $2.74M.
- Repertoire Partners's largest Q2 2022 buy was Tabula Rasa HealthCare, Inc. Common Stock: 1,067,710 shares worth $2.74M.
- Repertoire Partners added most to Ryder in Q2 2022, an estimated $7.94M increase.
- Repertoire Partners's biggest Q2 2022 reduction was BGC Group, cutting an estimated $20.8M.
- Repertoire Partners fully exited Mimecast Limited in Q2 2022, selling an estimated $80K.
- Repertoire Partners's ten largest holdings make up 84% of its $300M portfolio in Q2 2022.
- Repertoire Partners opened 40 new positions and closed 5 in Q2 2022.
- Repertoire Partners's portfolio value fell 80% quarter-over-quarter to $300M.
Based on Repertoire Partners's 13F filing for Q2 2022, filed 15 Aug 2022.